Association between 1019C/T polymorphism in the Connexin 37 gene and essential hypertension

Heart Lung and Circulation

Volumn 23, Issue 10, 2014, Pages 924-929

  Guo, Suxia ^a   Chen, Weixiang ^a   Yang, Ying ^a   Yang, Zhenyu ^a   Cao, Minghua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Allele frequency; C1019T; Connexin37gene; Essential hypertension; Genotype

Indexed keywords

CONNEXIN 37; GLUCOSE; GAP JUNCTION PROTEIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CX 37 GENE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; ESSENTIAL HYPERTENSION; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PATHOGENESIS; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CONNEXINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 84907788748     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.02.016     Document Type: Article

References (29)

1. Larsson E., Wahlstrand B., Hedblad B., Hedner T., Kjeldsen S.E., Melander O., et al. Hypertension and genetic variation in endothelial-specific genes. PLOS ONE 2013, 8(4):e62035.
2. Asai T., Ohkubo T., Katsuya T., Higaki J., Fu Y., Fukuda M., et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001, 38:1321-1324.
3. Glenn C.L., Wang W.Y., Morris B.J. Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension 1999, 33:927-932.
4. Rutherford S., Johnson M.P., Curtain R.P., Griffiths L.R. Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension. Hum Genet 2001, 109:408-415.
5. Tiret L., Poirier O., Hallet V., McDonagh T.A., Morrison C., McMurray J.J., et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999, 33:1169-1174.
6. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
7. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. International Consortium for Blood Pressure Genome-Wide Association Studies (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478: 103-109.
8. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
9. Levy D., Ehret G.B., Rice K., Verwoert G.C., Launer L.J., et al. Genomewide association study of blood pressure and hypertension. Nat Genet 2009, 41:677-687.
10. Newton-Cheh C., Johnson T., Gateva V., Tobin M.D., Bochud M., Coin L., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41:666-676.
11. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003, 83:1359-1400.
12. Fang J.S., Angelov S.N., Simon A.M., Burt J.M. Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol 2011, 301:H1872-H1881.
13. Kanady J.D., Dellinger M.T., Munger S.J., Witte M.H., Simon A.M. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 2011, 354:253-266.
14. Yeh H.I., Chang H.M., Lu W.W., Lee Y.N., Ko Y.S., Severs N.J., et al. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 2000, 48:1377-1389.
15. Pfenniger A., Wong C., Sutter E., Cuhlmann S., Dunoyer-Geindre S., Mach F., et al. Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells. J Mol Cell Cardiol 2012, 53:299-309.
16. Fang J.S., Angelov S.N., Simon A.M., Burt J.M. Cx40 is required for, and cx37 limits, postischemic hindlimb perfusion, survival and recovery. J Vasc Res 2012, 49:2-12.
17. Boerma M., Forsberg L., Van Zeij L., Morgenstern R., De Faire U., Lemne C., et al. A genetic polymorphismin connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999, 246:211-218.
18. Yeh H.L., Chou Y., Liu H.F., Chang S.C., Tsai C.H. Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 2001, 81:251-255.
19. Han Y.L., Xi S.Y., Zhang X.L., Yan C.H., Yang Y., Kang J. Association of C1019T polymorphism in the Connexin 37 gene and coronary artery disease in Chinese Han population. Zhonghua Yi Xue Za Zhi 2007, 87:100-104. (In Chinese).
20. Wong C.W., Christen T., Pfenniger A., James R.W., Kwak B.R. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction. Atherosclorosis 2007, 191:355-361.
21. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
22. Listi F., Candore G., Lio D., Russo M., Colonna-Romano G., Caruso M., et al. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 2005, 102:269-271.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572. [PMID: 12748199]. doi:10.1001/jama.289.19.2560.
24. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell 1996, 84. 381-318.
25. Mori Y., Ohyanagi M., Koida S., Ueda A., Ishiko K., Iwasaki T. Effects of Endothelium-Derived Hyperpolarizing Factor and Nitric Oxide on Endothelial Function in Femoral Resistance Arteries of Spontaneously Hypertensive Rats. Hypertens Res 2006, 29(3):187-195.
26. Sandow S.L., Bramich N.J., Bandi H.P., Rummery N.M., Hill C.E. Structure, function, and endothelium-derived hyperpolarizing factor in the caudal artery of the SHR and WKY rat. Arterioscler Thromb Vasc Biol 2003, 23:822-828.
27. + but may be due to spread of current from the endothelium in guinea pig arterioles. Am J Physiol 2001, 280:H2478-H2483.
28. Sandow S.L., Tare M., Coleman H.A., Hill C.E., Parkington H.C. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res 2002, 90:1108-1113.
29. Yeh H.I., Lee P.Y., Su C.H., Tian T.Y., Ko Y.S., Tsai C.H. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens. 2006, 19(2):129-135.